STOCK TITAN

Hyster-Yale SEC Filings

HY NYSE

Welcome to our dedicated page for Hyster-Yale SEC filings (Ticker: HY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Hyster-Yale, Inc. filings document operating results, Regulation FD presentations and governance matters for a public manufacturer of lift trucks, attachments, aftermarket parts and materials-handling technology. Form 8-K reports include earnings releases, historical quarterly financial schedules and investor presentations that discuss bookings, shipments, product mix, tariffs, cash flow, segment performance and risk factors.

Proxy materials disclose board composition, committee structure, risk oversight, governance policies, related-party transaction review, director elections, executive compensation, equity plan matters and auditor ratification. Other current reports record officer changes and compensatory arrangements, along with capital-structure and shareholder voting disclosures.

Rhea-AI Summary

Ann O'Hara, a director of Hyster-Yale, Inc. (HY), received 963 Class A common shares on 10/01/2025 as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan. The shares were awarded at a price of $0 and increased her beneficial ownership to 2,996 Class A common shares following the transaction. The Form 4 was executed by attorney-in-fact Suzanne S. Taylor on 10/02/2025. No derivative transactions or additional compensation details are reported in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Director Dennis W. LaBarre received equity on 10/01/2025 under Hyster-Yale's Non-Employee Directors' Equity Compensation Plan. The Form 4 shows an award of 963 shares of Class A common stock at a $0 price (an equity award, not a purchased transaction). After this award, the reporting person beneficially owns 35,609 shares of Class A common stock. The filing also reports 9,424 Class A shares referenced under derivative holdings, listed as directly beneficially owned. The transaction was reported by an attorney-in-fact signature dated 10/02/2025. This Form 4 documents a routine director equity grant and the resulting ownership positions without additional disclosures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Britton T. Taplin, a director of Hyster-Yale, Inc. (HY), reported on this Form 4 that on 10/01/2025 he was awarded 963 shares of Class A Common Stock as "Required Shares" under the companys Non-Employee Directors' Equity Compensation Plan. The filing lists the total Class A shares beneficially owned after the reported transactions across several indirect holdings: 387,117 shares held in trust for the reporting person, 108,844 shares reflecting a proportionate interest in Abigail LLC, 61,138 shares from Corky LLC, 11,510 shares held by spouse, and 11,143 held in a trust for the reporting person's children. The reporting person disclaims beneficial ownership of certain shares as noted in the form. The filing was signed by an attorney-in-fact on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Insider transaction summary: HYSTER-YALE director Edward T. Eliopoulos was reported on Form 4 as acquiring 963 shares of Class A common stock on 10/01/2025 at a reported price of $0. After the transaction, the reporting person beneficially owns 14,447 shares indirectly, held in a trust for his benefit. The filing was signed by an attorney-in-fact on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

David B. Williams, a director of Hyster-Yale, Inc. (HY), acquired 963 Class A common shares on 10/01/2025. The shares were issued as "Required Shares" under the companys Non-Employee Directors Equity Compensation Plan and were reported at a $0 price, reflecting a grant rather than a purchase. The filing lists extensive indirect holdings attributed to the reporting person through spouse, trusts, and partnership interests, including large blocks of Class A shares underlying Class B holdings reported in Table II. The reporting person disclaims beneficial ownership of several indirectly held positions. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Claiborne R. Rankin, a director of Hyster-Yale, Inc. (HY), reported an acquisition of 963 shares of Class A common stock on 10/01/2025 as "Required Shares" under the companys Non-Employee Directors Equity Compensation Plan. After the reported transaction, the filing shows 243,245 shares of Class A common stock beneficially owned by the reporting person, largely held indirectly through trusts, limited partnerships and interests attributed to the reporting persons spouse. The Form 4 discloses multiple indirect holdings and trustee roles rather than open-market purchases or sales, and the reporting person disclaims beneficial ownership for certain trust-held shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Reporting person: Poor Vincent, listed as a director of HYSTER-YALE, INC. (HY). On 10/01/2025 Mr. Vincent was awarded 963 shares of Class A Common Stock as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan at a reported price of $0. After the award he beneficially owned 20,451 shares, held directly. The Form 4 was signed by an attorney-in-fact, Suzanne S. Taylor, on 10/02/2025.

This filing documents a routine equity award to a director recorded as a non-derivative acquisition; it shows the change in direct beneficial ownership and identifies the award as compensation-related under the director equity plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The reporting person, John P. Jumper, a director of Hyster-Yale, received 963 shares of Class A common stock as award "Required Shares" under the companys Non-Employee Directors' Equity Compensation Plan. Following the transaction the reporting person beneficially owns 26,837 shares of Class A common stock. The Form 4 indicates this was a non-derivative acquisition recorded with transaction code A and a $0 price, consistent with stock awards issued as compensation to a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Carolyn Corvi, a director of HYSTER-YALE, INC. (HY), reported an acquisition of 963 shares of Class A common stock on 10/01/2025. The reported transaction code is A (acquisition) at a reported price of $0.00, leaving her with 26,185 shares beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on 10/02/2025. The filing is a single-person Form 4 and lists the reporting person as a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Gary Collar L, a director of HYSTER-YALE, INC. (HY), received equity awards on 10/01/2025 under the company's Non-Employee Directors' Equity Compensation Plan. The filing shows two grant entries: 963 shares issued as "Required Shares" and 648 shares issued as "Voluntary Shares," both with a $0 price, indicating they were awarded rather than purchased. After the transactions the reporting person is shown as directly owning 6,729 shares of Class A common stock. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Hyster-Yale (HY) SEC filings are available on StockTitan?

StockTitan tracks 125 SEC filings for Hyster-Yale (HY), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Hyster-Yale (HY)?

The most recent SEC filing for Hyster-Yale (HY) was filed on October 2, 2025.